For Investors

Regulatory Insight for Better Investment Decisions

Every investment decision balances opportunity against risk. In medical technology, one of the most significant - and often least understood - risks is regulatory strategy.

Regulatory decisions influence development timelines, capital requirements, clinical strategy, reimbursement planning, commercialization, and ultimately company valuation. Yet most investment teams are not expected to have deep expertise in FDA regulations, EU MDR, or global regulatory pathways. Likewise, founders are often navigating these challenges for the first time.

I help bridge that gap by providing independent, practical regulatory insight that helps investors make more informed decisions before and after an investment.

Regulatory Diligence
A company's regulatory strategy can significantly influence the time, capital, and execution required to reach commercialization.

I provide focused regulatory diligence that helps investors understand whether a company's proposed regulatory pathway is realistic, identify materal regulatory risks, and evaluate whether development plans aligh with regulatory expectations.

Typical areas of review include:
  • FDA and international regulatory pathway strategy
  • Device classification, product code, risk level, and intended use
  • Clinical evidence requirements
  • EU MDR readiness
  • Regulatory timeline realism
  • Quality system maturity
  • Technical documentation readiness
  • Key regulatory risks that may impact valuation or commercialization
Portfolio Advisory
Regulatory questions don't stop after a financing round.

As portfolio companies grow, they encounter new regulatory decisions that influence product development, financing milestones, market expansion, and exit readiness.

I provide ongoing strategic support to investment teams and portfolio companies, serving as an experienced regulatory advisor when questions arise.

Support may include:
  • Strategic regulatory guidance for portfolio companies
  • Review of evolving regulatory plans
  • ndependent perspective on significant regulatory decisions
  • Executive-level discussions with founders and leadership teams
  • Preparation for future financing, partnerships, or acquisition diligence

Let's Start a Conversation

Whether you're evaluating a new investment, supporting an existing portfolio company, or looking for an experienced regulatory advisor, I'd be happy to discuss how I can help.
Feel free to email me at ashley@raadstrategies.com
Or grab a spot on my calendar:

My Calendar